Here are the 424B prospectus supplements from Alzamend Neuro, Inc. (ALZN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow ALZN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALZN filings page.
Alzamend Neuro, Inc. has filed a prospectus supplement to sell up to $3,000,000 of its common stock in an at-the-market offering through Ascendiant Capital Markets, LLC.
The sales agent will act as an agent or principal and receive a fee equal to 3% of gross proceeds. As of the prospectus supplement date, there were 3,804,741 shares issued and outstanding.